trial

Predicting Antipsychotic Discontinuation in Psychosis

NCTId NCT02884518
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 35 (actual)
Sponsored by Seoul National University Hospital
Primary completion 2019-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
35 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2016-10-04
Primary completion
2019-12
Eligibility
ALL · 19 Years · 45 Years

Interventions & indications

Drugs
PETclinical scale

Sponsors

Seoul National University HospitalLead Sponsor

Investigators

1
Euitae Kim, Ph. D.Study Chair

Sites

1 total
Seongnam-si, South Korea

Facts & assertions

4 sourced
Enrollment
35
Phase
NA
Primary Completion Date
2019-12
Status
UNKNOWN
relationships
The graph out of here
drug
PET
drug
clinical scale
drug
lead_sponsor
Seoul National University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Euitae Kim, Ph. D.
person